You are here

Xyphos Biosciences

Astellas-owned Xyphos offers more than $800M for Kelonia's in vivo delivery know-how

Fierce Biotech

Thu, 02/15/24 - 07:21 pm

Xyphos Biosciences

Corporate and regulatory developments over the Christmas period

EP Vantage

Thu, 01/2/20 - 11:39 pm

Ono Pharmaceutical

Xyphos Biosciences

Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million

Reuters

Mon, 12/30/19 - 10:59 am

Xyphos Biosciences

Audentes Therapeutics

Parker Institute backs an upstart biotech looking to develop a new, convertible CAR-T

Endpoints

Thu, 10/18/18 - 11:27 pm

Xyphos Biosciences